Naba Al Saha Medical Services (9546) Stock Overview
Operates private and governmental hospitals, and health facilities in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
9546 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Naba Al Saha Medical Services Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س48.80 |
| 52 Week High | ر.س97.00 |
| 52 Week Low | ر.س46.78 |
| Beta | -0.48 |
| 1 Month Change | -2.36% |
| 3 Month Change | -11.43% |
| 1 Year Change | -38.23% |
| 3 Year Change | 52.82% |
| 5 Year Change | n/a |
| Change since IPO | 39.16% |
Recent News & Updates
Naba Al Saha Medical Services Company's (TADAWUL:9546) Price Is Out Of Tune With Earnings
Dec 22
Naba Al Saha Medical Services Company's (TADAWUL:9546) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Apr 17Recent updates
Naba Al Saha Medical Services Company's (TADAWUL:9546) Price Is Out Of Tune With Earnings
Dec 22Naba Al Saha Medical Services Company's (TADAWUL:9546) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Apr 17Returns On Capital At Naba Al Saha Medical Services (TADAWUL:9546) Paint A Concerning Picture
Mar 18Naba Al Saha Medical Services' (TADAWUL:9546) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Sep 07Returns At Naba Al Saha Medical Services (TADAWUL:9546) Appear To Be Weighed Down
Aug 27We Ran A Stock Scan For Earnings Growth And Naba Al Saha Medical Services (TADAWUL:9546) Passed With Ease
Apr 02The Returns At Naba Al Saha Medical Services (TADAWUL:9546) Aren't Growing
Jan 17Shareholder Returns
| 9546 | SA Healthcare | SA Market | |
|---|---|---|---|
| 7D | -4.1% | -0.7% | 0.9% |
| 1Y | -38.2% | -23.1% | -9.0% |
Return vs Industry: 9546 underperformed the SA Healthcare industry which returned -23.1% over the past year.
Return vs Market: 9546 underperformed the SA Market which returned -9% over the past year.
Price Volatility
| 9546 volatility | |
|---|---|
| 9546 Average Weekly Movement | 8.0% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in SA Market | 6.9% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 9546's share price has been volatile over the past 3 months compared to the SA market.
Volatility Over Time: 9546's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of SA stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | n/a | Nathir Mohammed Hassan Al-Jishi | www.nams.sa |
Naba Al Saha Medical Services Company operates private and governmental hospitals, and health facilities in the Kingdom of Saudi Arabia. It owns, operates, and manages Al-Zahraa Hospital, Manarat Al-Haramain Pharmacy, and Nabea Al-Sahha branch. The company provides outpatient, inpatient, and operation services, as well as maintenance and cleaning services; and building operation services.
Naba Al Saha Medical Services Company Fundamentals Summary
| 9546 fundamental statistics | |
|---|---|
| Market cap | ر.س520.38m |
| Earnings (TTM) | ر.س22.95m |
| Revenue (TTM) | ر.س196.10m |
Is 9546 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9546 income statement (TTM) | |
|---|---|
| Revenue | ر.س196.10m |
| Cost of Revenue | ر.س135.50m |
| Gross Profit | ر.س60.60m |
| Other Expenses | ر.س37.66m |
| Earnings | ر.س22.95m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.19 |
| Gross Margin | 30.90% |
| Net Profit Margin | 11.70% |
| Debt/Equity Ratio | 40.3% |
How did 9546 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/09 16:16 |
| End of Day Share Price | 2026/02/09 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Naba Al Saha Medical Services Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.